Delivery Order SPE2DB24D1021-SPE2DB25FEYCN
Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $3,391.96 and a performance period ending on July 10, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any special business categories....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $19,297.83 and a performance period through May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $3,746.52 and a period of performance through June 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $9,995.66. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $11,594.32 and a period of performance ending on July 8, 2025. The contract is a firm-fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $17,474.70 and a performance period through June 17, 2025. The contract is not set-aside and was awarded on June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a ceiling value of $8,992.59 and a period of performance ending on April 23, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $9,172.59 and a period of performance ending on July 16, 2025. The contract is a firm-fixed price delivery order, which is not set aside for any specific business type. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $3,853.77 and a period of performance ending on June 16, 2025. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $16,872.83 and a completion date of July 3, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...